-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Downgrades Black Diamond Therapeutic to Neutral

Benzinga·12/04/2025 13:48:00
Listen to the news
Guggenheim analyst Brad Canino downgrades Black Diamond Therapeutic (NASDAQ:BDTX) from Buy to Neutral.